Hemophilia Therapies: Factor Replacement and Emicizumab
Lisa Schrade, PharmD, discusses factor replacement therapies and emicizumab’s role in treating hemophilia.
Stay updated with breaking news from Clotting Cascade. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lisa Schrade, PharmD, discusses factor replacement therapies and emicizumab’s role in treating hemophilia.
The Atlantic The Danger of a ‘Dudes Only’ Vaccine We still don’t know who’s most at risk of getting the Johnson & Johnson vaccine blood clots. Katie Martin / The Atlantic The Johnson & Johnson shot is teetering on the precipice of becoming America’s “dudes only” vaccine. On Tuesday, the CDC and FDA advised halting the vaccine’s nationwide rollout to investigate six cases of a rare blood-clotting disorder that’s occurred in people within about two weeks of receiving the vaccine—all of them women under the age of 50. In an emergency meeting convened Wednesday by the CDC, exp...